ArticleMovement disorders : official journal of the Movement Disorder Society2026
The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.
Julie Fortin, Matthis Synofzik, Élyse-Anne Pedneault-Tremblay, Dominik Hermle, Andreas Thieme, Dagmar Timmann, Roberta La Piana, Bernard Brais, Justine Dolbec, Isabelle Côté and 2 more
Abstract read
In one paragraphArticle in Movement disorders : official journal of the Movement Disorder Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Julie FortinGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0003-1957-8518 Matthis SynofzikDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-2280-7273 Élyse-Anne Pedneault-TremblayGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0009-0001-4612-9008 Dominik HermleDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0009-0006-3266-2203 Andreas ThiemeDepartment of Neurology and Center for Translational Neuro- and Behavioral StudiesSciences (C-TNBS), Essen University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0001-6221-8601 Dagmar TimmannDepartment of Neurology and Center for Translational Neuro- and Behavioral StudiesSciences (C-TNBS), Essen University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0003-1935-416X Justine DolbecGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.
Isabelle CôtéGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0002-8360-9086 Cynthia GagnonGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0003-2829-8470 Andreas TraschützDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-8165-5898 Funding
Clinician Scientist program "PRECISE.net"Consortium international, including the Canadian Institutes of Health Research, Ataxia Charlevoix-Saguenay Foundation and Muscular Dystrophy CanadaEJP RD consortium TREAT-ARCA 01GM2005European Joint Programme on Rare Diseases 825575European Union, project European Rare Disease Research Alliance (ERDERA) 101156595HORIZON-HLTH-2023-DISEASE-07
6 · The paper itselfAbstract
backgroundNeuropsychological deficits have been observed in patients with cerebellar damage, but never thoroughly investigated in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
objectivesThe goal is the characterization of presence, severity, and profile of neuropsychological deficits in ARSACS using the cerebellar cognitive-affective syndrome (CCAS) scale.
methodsProspective study including a discovery cohort from Saguenay/Canada (n = 31, median [inter-quartile range] age: 57 [54-62] years), and a validation cohort from Tübingen, Germany (n = 17, 35 [21-43] years) with matched controls (n = 19).
resultsAll ARSACS patients failed in multiple CCAS-related subtests and exceeded cutoffs for "definite CCAS." Even the younger validation cohort failed more subtests than controls (5 [3-7] vs. 1 [1-2], P < 0.001) and had lower CCAS total scores (81 [67-86] vs. 101 [91-106], P < 0.001). Total scores worsened in the older discovery cohort (40 [25-52], P < 0.001) and correlated with age/disease duration (ρ = -0.575, P < 0.001) and ataxia severity (Scale for the Assessment and Rating of Ataxia: ρ = -0.527, P = 0.003).
conclusionsNeuropsychological deficits consistent with CCAS are consistent in ARSACS, present early, and progress in the disease course. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Indexed as
Cerebellar Cognitive Affective SyndromeMuscle SpasticitySpinocerebellar AtaxiasAdultCross-Sectional StudiesDisease ProgressionFemaleHumansMaleMiddle AgedNeuropsychological TestsProspective StudiesSeverity of Illness IndexYoung Adultcerebellar cognitive‐affective syndromecognitionmovement disordersneuropsychologyspastic ataxia of Charlevoix‐Saguenay
Identifiers
PMID41669957
PMCPMC13067325
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390